Skip to main content
Clinical Trials/ISRCTN25071503
ISRCTN25071503
Completed
Phase 1

Pregnant women with type 1 diabetes - does wearable technology improve outcomes?

niversity of Ulster0 sites20 target enrollmentAugust 24, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Pregnant women with type 1 diabetes
Sponsor
niversity of Ulster
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 24, 2021
End Date
July 14, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
niversity of Ulster

Eligibility Criteria

Inclusion Criteria

  • 1\. Women with T1D in the first trimester of pregnancy
  • 2\. Aged 18 \- 50 years old
  • 3\. Duration of diabetes \>1 year
  • 4\. Using multiple daily injections or insulin pump therapy
  • 5\. Using an interstitial glucose sensor
  • 6\. BMI \<40 kg/m²
  • 7\. Have undertaken a program of structured education for carbohydrate counting
  • 8\. Able to understand English

Exclusion Criteria

  • 1\. Less than 18 years of age
  • 2\. Type 2 diabetes (T2D) or a genetic variant of diabetes
  • 3\. Diagnosed \<1 year
  • 4\. Not using multiple daily injections or an insulin pump
  • 5\. Have not undertaken a program of structured education including carbohydrate counting
  • 6\. \>13 weeks pregnant at the time of presenting to the antenatal clinic
  • 7\. Unable to read or understand English

Outcomes

Primary Outcomes

Not specified

Similar Trials